Company / Working Capital
TEVA PHARMACEUTICAL INDUSTRIES LTD Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$490.0M
FY2025
5-year range
-$244.0M / $1.5B
FY2021-FY2025
Trend
+300.8%
vs FY2024
Sector context
#94 of 213
Health Care
What the data says
Working Capital changed +301% YoY in FY2025, a notable deviation from the 9-year average annual change of +123%.
Based on SEC 10-K filings.
$490M in FY2025 with a 3-year CAGR of -5.6%.
Improved from $238M to $490M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -5.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#94 of 213 in Health CareTop 44% of 213This company $490.0M Sector average $934.6M
▼
-47.6% below sector average
Key checks
Key Insights
- 3-year CAGR of -5.6%, indicating a declining trend.
- In FY2025, working capital increased 300.8% year-over-year.
- Ranks #94 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $490.0M | +300.8% |
| FY2024 | -$244.0M | -202.5% |
| FY2023 | $238.0M | -59.1% |
| FY2022 | $582.0M | -62.4% |
| FY2021 | $1.5B | +1072.3% |
| FY2020 | -$159.0M | +24.3% |
| FY2019 | -$210.0M | +60.2% |
| FY2018 | -$528.0M | +79.2% |
| FY2017 | -$2.5B | -101.5% |
| FY2016 | -$1.3B | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026